The Converge Advisory Group serves as trusted and unbiased advisors by focusing exclusively on helping our clients bring innovative medicines to market faster and with a greater probability of success.
Robert S. Liebman, MBA Managing Director
Robert co-founded and serves as a Managing Director with the Converge Advisory Group and has more than 20 years of experience driving improved business performance in his clients businesses
Prior to co-founding the Converge Advisory Group, Robert was a Principal and member of the Quintiles Advisory Services leadership team. Previously, he founded the Bedrock Consulting Group, a specialty consulting firm focused on global operations strategy. Robert also held leadership positions with PwC (formerly PRTM) and Archstone Consulting. Robert’s client work includes a full range of engagements across the product lifecycle with a focus on clinical and commercial strategies.
Subha B. Basu, PhD/MBA Managing Director
Subha co-founded and serves as a Managing Director with the Converge Advisory Group and has over 20 years of academic, industry and consulting experience.
Prior to co-founding the Converge Advisory Group, Subha held senior positions with Decision Resources Group, Quintiles Advisory Services, Frost & Sullivan and Becton Dickinson.
Subha has extensive exposure to opportunity assessment, emerging markets and strategy development in pharma, bioprocessing, medtech and biosimilars sectors.